Loading chart…
PRE-MARKET
Neuland Laboratories Limited engages in the manufacture and sale of active pharmaceutical ingredients (APIs) in India, Europe, the United States, and internationally. It also provides custom manufacturing solutions, generic drug substances, as well as peptide APIs and synthesis services. The company serves generic companies, regional and domestic pharmaceutical manufacturers, distributors, and other pharmaceutical and biotechnology companies.
Neuland Laboratories Limited (NEULANDLAB) is listed on the NSE in the Healthcare sector, Drug Manufacturers - Specialty & Generic industry. The NEULANDLAB share price is ₹19,836.00 (+0.27% today), with a market capitalisation of ₹254B and a price-to-earnings (P/E) ratio of 56.2. MarketRipple tracks the NEULANDLAB investment thesis, the ripple-chain impact of market events on Neuland Laboratories Limited, and the Healthcare sector outlook.
Open
₹19,700.00
High
₹19,954.00
Low
₹19,598.00
Prev. Close
₹19,783.00
52W High
₹24,225.00
52W Low
₹11,500.00
Day range
₹19,598.00–₹19,954.00
52-week range
₹11,500.00–₹24,225.00
Volume
4K
P/E
56.2
ROE
24.8%
D/E
0.16
Margin
19.6%
Neuland Laboratories Limited (NSE: NEULANDLAB) is currently trading at ₹19,836.00 (+0.27%).
Neuland Laboratories Limited's market capitalization is ₹254B.
Neuland Laboratories Limited's price-to-earnings (P/E) ratio is 56.2.
Neuland Laboratories Limited operates in the Healthcare sector (Drug Manufacturers - Specialty & Generic).
Analyst consensus on Neuland Laboratories Limited currently reads strongly positive, based on 4 analysts covering the stock. This is third-party analyst data, not a MarketRipple recommendation.